 |
|
mapatumumab
A fully human agonistic monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) with apoptosis promoting and potential antitumor activities. TRAIL-R1 is a cell surface receptor expressed on many malignant cell types. Mapatumumab selectively binds to and activates the TRAIL cell receptor, thereby inducing apoptosis and reducing tumor growth. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | Anti-TRAIL R1-mAb | | | | Abbreviation: | | TRM-1 mAb | | | | Code name: | | HGS-ETR1 | | |
|
|
